Inventor
SABAT MARK
US20 patents
⚠️ This page may combine multiple inventors who share the name “SABAT MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROCTER & GAMBLE
6 patentsUS7256196B1Aug 14, 2007
Purine cytokine inhibitors
PROCTER & GAMBLE33 citations92
US7319102B1Jan 15, 2008
Pyrrolo[2,3-d]pyrimidine cytokine inhibitors
PROCTER & GAMBLE14 citations83
US6849627B2Feb 1, 2005
6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
PROCTER & GAMBLE2 citations61
US7402589B2Jul 22, 2008
Tri-substituted ureas as cytokine inhibitors
PROCTER & GAMBLE0 citations49
US7449474B2Nov 11, 2008
Tri-substituted ureas as cytokine inhibitors
PROCTER & GAMBLE1 citations46
US7482356B2Jan 27, 2009
Bicyclic pyrazolone cytokine inhibitors
PROCTER & GAMBLE0 citations39
CHERUVALLATH ZACHARIA
4 patentsUS8530499B2Sep 10, 2013
Glucokinase activators
CHERUVALLATH ZACHARIA2 citations59
US8163779B2Apr 24, 2012
Glucokinase activators
CHERUVALLATH ZACHARIA2 citations59
US8563730B2Oct 22, 2013
Pyrazole and fused pyrazole glucokinase activators
CHERUVALLATH ZACHARIA1 citations48
US8173645B2May 8, 2012
Glucokinase activators
CHERUVALLATH ZACHARIA0 citations38
TAKEDA PHARMACEUTICALS CO
4 patentsUS10307414B2Jun 4, 2019
Pyridinyl and fused pyridinyl triazolone derivatives
TAKEDA PHARMACEUTICALS CO0 citations51
US9801872B2Oct 31, 2017
Pyridinyl and fused pyridinyl triazolone derivatives
TAKEDA PHARMACEUTICALS CO1 citations51
US9402841B2Aug 2, 2016
Pyridinyl and fused pyridinyl triazolone derivatives
TAKEDA PHARMACEUTICALS CO1 citations51
US9598424B2Mar 21, 2017
Heteroarylamide inhibitors of TBK1
TAKEDA PHARMACEUTICALS CO0 citations40